Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.64 $25,306 - $62,293
-97,334 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.52 - $1.0 $13,670 - $26,290
-26,290 Reduced 21.27%
97,334 $58,000
Q4 2021

Feb 15, 2022

BUY
$0.85 - $1.33 $7,818 - $12,233
9,198 Added 8.04%
123,624 $121,000
Q3 2021

Nov 15, 2021

SELL
$1.03 - $1.41 $184,443 - $252,490
-179,071 Reduced 61.01%
114,426 $149,000
Q2 2021

Aug 16, 2021

BUY
$1.04 - $1.5 $305,236 - $440,245
293,497 New
293,497 $323,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.